Charm Care Corporation

6062.T
Medical Care Facilities
2026/08/21 Updated
Market Cap: $238.8M (¥38.0B)
Stock Price: $8.88 (¥1,412)
Exchange Rate: 1 USD = ¥158.98

【Charm Care】Full-Year Earnings Forecast Revision and Dividend Increase | May 2026

Announced a revision to the full-year earnings forecast for the fiscal year ending June 2026, increasing sales by 185 million yen and net income by 480 million yen. Dividends have also been increased to 43 yen, strengthening shareholder returns.

Importance:
Page Updated: May 25, 2026
IR Disclosure Date: May 25, 2026

Key Figures

  • Net sales: 48,770 million yen (up 0.4% from previous forecast)
  • Operating income: 5,150 million yen (up 15.5% from previous forecast)
  • Net income attributable to owners of parent: 3,570 million yen (up 15.5% from previous forecast)

AI要約

Performance Overview

Charm Care Corporation has revised its full-year earnings forecast for the fiscal year ending June 2026 to net sales of 48,770 million yen (up 185 million yen from the previous forecast), operating income of 5,150 million yen (up 690 million yen), and net income of 3,570 million yen (up 480 million yen). This improvement is due to increased productivity in the caregiving business and the signing of contracts related to real estate sales. Compared to the same period last year, sales are on an upward trend, and profitability has also improved.

Impact on Shareholders and Future Outlook

The dividend forecast has been increased, with the year-end dividend rising from 23 yen to 43 yen. The annual dividend increased from 37 yen to 43 yen, maintaining a stable shareholder return with a payout ratio of 39.4%. Going forward, based on steady business performance and profit improvements, the company aims to enhance shareholder value and maintain financial health by balancing growth investments and dividends.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Charm Care Corporation

Company overview · Stock price · Financial data · All IR

View company page →